Size-exclusion chromatography (SEC) separates proteins by hydrodynamic size, but a retention time alone does not give a molecular weight: the elution position depends on shape as well as mass, and two proteins of the same mass can elute differently if one is compact and the other extended. Coupling SEC to multi-angle light scattering (SEC-MALS) removes that ambiguity. Light scattering measures the absolute molar mass of each eluting species directly, without column calibration or reference standards, and simultaneously reports the size (radius of gyration) and the aggregation state. For any protein whose oligomeric state or aggregation behaviour matters — a therapeutic antibody, an enzyme complex, a designed assembly — SEC-MALS answers the question SEC alone can only hint at.
What the technique measures
A MALS detector measures the intensity of light scattered by the eluting solute at several angles. Because the excess Rayleigh ratio is proportional to the product of the weight-average molar mass and the concentration, combining the light-scattering signal with a concentration detector (typically a differential refractive index, dRI) yields the absolute molar mass at every point across a peak. The angular dependence of the scattering gives the radius of gyration (Rg), a shape-sensitive size parameter. Practically, the key outputs are:
- Absolute molar mass (Mw) across each peak — e.g. 150 kDa for a monomeric IgG, 300 kDa for a dimer.
- Oligomeric state — inferred by comparing the measured mass to the sequence-derived monomer mass.
- Mass distribution / polydispersity — whether an apparently single peak contains more than one species.
- Aggregate content — high-molar-mass species eluting before the main peak, quantified by the UV or dRI trace.
Instrument setup
A typical configuration is HPLC/SEC → UV → MALS → dRI in series. The order matters: UV and MALS should see the sample before the dRI, and the dRI cell must be thermostatted, because its signal is strongly temperature-sensitive. Run the system with a matched isocratic pump, a low-volume inline filter, and PEEK or stainless tubing sized to minimise band broadening. Calibrate the MALS detector with a known isotropic scatterer (toluene) and normalise the photodiodes against a standard protein of known mass (e.g. BSA monomer, 66.4 kDa) before the run.
Column and mobile phase
- Column: a silica-based SEC column with a pore size matched to the protein's mass range (e.g. 300 Å for globular proteins up to ~1 MDa). Guard column in place; never let the column run dry or exceed its pressure limit.
- Mobile phase: use the protein's own formulation buffer where possible, filtered (0.1 µm) and degassed. Add 100–300 mM salt to suppress non-specific electrostatic interactions with the matrix; SEC interactions with the column are the most common cause of anomalous elution.
- Flow rate: typically 0.3–0.5 mL/min for analytical SEC-MALS. Faster runs trade resolution and detector equilibration for time.
- Temperature: hold column and detectors at 25 °C unless the protein demands otherwise; record the dRI temperature, since a 1 °C drift changes the refractive index increment.
- Injection: 20–100 µL of sample at 0.5–2 mg/mL. Enough mass is needed for a good light-scattering signal, but overloading the column broadens peaks and promotes interaction artefacts.
Procedure
- Equilibrate the column and all detectors with filtered, degassed mobile phase until the UV, MALS, and dRI baselines are flat and stable (typically 30–60 min).
- Normalise the MALS photodiodes using the manufacturer's standard or a known protein standard; verify the calibration by running a BSA monomer and confirming recovery of ~66.4 kDa.
- Measure the refractive index increment (dn/dc) for the buffer, or use the accepted 0.185 mL/g for proteins in aqueous buffer. The dRI concentration is only as accurate as this value.
- Inject the buffer blank to establish the baseline, then inject the protein sample. Record UV, MALS, and dRI traces.
- Analyse with the instrument software (e.g. ASTRA or equivalent): define the peak(s), set the baseline, and compute Mw and Rg across the peak. Report the mass at the peak apex and the polydispersity across the peak.
- Run at least duplicate injections and, where the protein's stability is in question, a sample held at the intended storage temperature as a control.
Interpreting the data
- Mass matches monomer: the protein is monomeric under these conditions. Note that the measured mass is a weight average; a small population of dimer can hide within a nominally monomeric peak.
- Mass ≈ 2× monomer: a stable dimer. Confirm it is not a light-scattering artefact of an unusually large or highly glycosylated monomer by checking Rg and by orthogonal methods (analytical ultracentrifugation, native mass spectrometry).
- Mass increasing across a peak: polydisperse or self-associating species; the average is concentration-dependent and the sample should be reported as heterogeneous.
- High-mass peak eluting early: aggregate. Quantify its area fraction from the UV or dRI trace.
- Negative or low apparent mass: usually a baseline or calibration problem, or a buffer mismatch between sample and mobile phase — not a real result.
Common artefacts and troubleshooting
- Column interaction: protein eluting later than expected or with a tailing peak. Increase salt, adjust pH, or switch to a column with a different chemistry.
- Band broadening: excessive tubing volume between detectors degrades resolution and blurs the mass across a peak. Keep inter-detector volume minimal.
- Bubble or particulate in dRI: erratic baseline. Filter and degas the mobile phase, and check the inline filter.
- Detector misalignment: Rg values that are nonsensical or negative. Re-normalise the photodiodes and verify the calibration protein.
- Glycosylation and dn/dc: heavily glycosylated proteins have a different dn/dc than unmodified ones; the mass estimate can be biased if the default is used uncritically.
Reporting
Report the column and mobile phase, flow rate, temperature, injection volume and concentration, the calibration standard, the assumed dn/dc, the measured Mw (with uncertainty) and Rg for each peak, the derived oligomeric state, and the aggregate fraction. State whether results are from single or duplicate injections, and note any column interaction. When SEC-MALS is used to support a stability or comparability claim, pair it with a technique that reports on tertiary structure and conformational stability — CD, DSC, or nanoDSF — because a protein can be monomeric and yet conformationally compromised, and vice versa.
References
- Wyatt PJ. Multiangle light scattering from separated samples (MALS with SEC or FFF). In: Encyclopedia of Biophysics. Berlin: Springer; 2013:1619–1625. doi:10.1007/978-3-642-16712-6_282
- Folta-Stogniew E. Oligomeric states of proteins determined by size-exclusion chromatography coupled with light scattering, absorbance, and refractive index detectors. In: New and Emerging Proteomic Techniques. Methods Mol Biol. 2006;328:97–112. doi:10.1385/1-59745-026-x:97
- Ye H. Simultaneous determination of protein aggregation, degradation, and absolute molecular weight by size exclusion chromatography–multiangle laser light scattering. Anal Biochem. 2006;356(1):76–85. doi:10.1016/j.ab.2006.05.025
- Diederich P, Hansen SK, Oelmeier SA, et al. A sub-two minutes method for monoclonal antibody-aggregate quantification using parallel interlaced size exclusion high performance liquid chromatography. J Chromatogr A. 2011;1218(51):9010–9018. doi:10.1016/j.chroma.2011.09.086
- Schuck P. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal Biochem. 2003;320(1):104–124. doi:10.1016/s0003-2697(03)00289-6
- Wyatt PJ. Light scattering and the solution properties of macromolecules. In: Handbook of Size Exclusion Chromatography and Related Techniques. 2nd ed. New York: CRC Press; 2003:chap 21. doi:10.1201/9780203913321.ch21